Clinical Trials Browser

Non-squamous Non-small-cell Lung Cancer × lenvatinib × Clear all

NCT05258279 2024-08-28

Lenvatinib in Combination With Carboplatin Pemetrexed and Pembrolizumab for NSCLC With EGFR Mutations

Phase 2 Active not recruiting

Non-squamous Non-small-cell Lung Cancer